AstraZeneca submits Brilinta for FDA approval

11/19/2009 | Reuters

AstraZeneca filed for FDA approval of Brilinta, a promising rival to blockbuster blood thinner Plavix. The application comes months after AstraZeneca reported that Brilinta outperformed Plavix in a late-stage study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX